Powell and Warsh A Historic Fed Coexistence Raises Questions About Policy Direction
UnRetirement Trend Accelerates as Older Americans Rejoin Workforce for Financial Security
Roth Capital Maintains Its Stance on T1 Energy Following Internal Discussion
Trump Pressures Bank of America and JPMorgan Over Claims of Conservative Discrimination
Novartis Upgrades FullYear Outlook on Strong Operational Performance
Irans Potential Tariffs on Hormuz Internet Cables Could Raise Costs for Europe
ETON Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges
ELS Q1 2026 Earnings Modest EPS Beat Amid Stable Operating Performance
Braze Inc Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction
UZF Q1 2026 Earnings Strong EPS Beat Signals Operational Efficiency
Winmark Corporation WINA Q1 2026 Earnings EPS Misses Estimates Amid Margin Headwinds
BlackRock Q1 2026 Earnings Strong EPS Beat Driven by Robust Fee Income and Asset Growth
Neuronetics STIM Rallies 2 as Shares Test Key Resistance Levels
Pacific Biosciences Up 238 Testing Resistance Amid Sector Rotation
NCR Voyix VYX Gains 24 as Shares Test Key Levels
Nexstar Media Group NXST Edges Higher as Stock Consolidates Near Key Resistance
Nurix Therapeutics NRIX Edges Higher as Biotech Sector Focus Intensifies Key Levels in Play
Morgan Stanley Adjusts Palo Alto Networks PANW Price Target Amid Shifting Cybersecurity Demand Trends
CSIQ Q1 2026 Earnings NarrowerThanExpected Loss Shows Cost Discipline Amid Solar Market Challenges
Wolfspeed Surges Over 4 as Bullish Momentum Builds
PTON Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher Amid Operational Updates
GRWG Q1 2026 Earnings Narrow EPS Beat Highlights Cost Discipline Amidst Market Challenges
Actinium Pharmaceuticals ATNM Q1 2026 Earnings Narrower Loss Beats Expectations as Development Pipeline Advances
BayCom Corp Q1 2026 Earnings EPS Smashes Estimates by 226 but Shares Slip
BUSE Q1 2026 Earnings EPS Beat by 132 with Strong Core Performance
CPS Q1 2026 Earnings Earnings Miss Estimates Significantly as EPS Falls Short
Damora Therapeutics Q1 2026 Earnings WiderThanExpected Loss Despite Stock Gain